11011 Torreyana Rd.
Embedded in everything we do at BioDuro is the reality that the product we help create has the potential to cure patients. It’s that constant reminder that motivates us to transform the way pharmaceuticals are made. From drug substance to drug product, discovery to development, small molecule or biologics, BioDuro’s solutions provide pharmaceutical and biopharmaceutical companies with the quality results they need to help deliver their drugs to patients.
34 articles about BioDuro
BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China for the Discovery of New Small Molecule Drugs
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs.
BioDuro-Sundia Completes First GMP Drug Product Manufacturing at New China Site
Team scores perfect quality record, initiating production facility with capacity of 60 million oral dosage form units
BioDuro and Sundia Partner as an Industry Leading Contract Research, Development and Manufacturing Organization
BioDuro, a global life science research and development organization backed by Advent International (“Advent”), and Sundia, a leading contract research and manufacturing organization, today announced that they have partnered to create one of the largest CRDMOs (contract rese
BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform
Companies Combine Leading-edge AI Antibody Evolution & Advanced Synthetic Antibody Screening --
BioDuro Strengthens Senior Leadership of Global CMC Solutions Business Unit
BioDuro, LLC, announced today the appointment of two senior leadership positions to the Global CMC Solutions business unit: Firouz Asgarzadeh, PhD as Vice President of Pharmaceutics and Mindy Weir as Executive Director Quality. “BioDuro is
BioDuro Launches New Antibody & Cell Therapy Discovery Services
BioDuro LLC, a leading global life sciences contract research and development organization, announced today that it has broadly launched new antibody- and cell-based therapy discovery services.
BioDuro Welcomes New President, Global CMC Solutions
BioDuro, LLC, a leading global life sciences contract research, development and manufacturing services organization, is pleased to announce the appointment of Kent Payne, Ph.D., as President of its CMC Global Solutions business unit.
BioDuro chooses SciFinder-n from CAS to enhance research productivity and shorten cycle times for client success
Collaboration between drug companies and contract research partners drives innovation in evolving business environment
BioDuro Welcomes New Chief Financial Officer
BioDuro, LLC, a leading global life sciences contract research, development and manufacturing services organization, announced today the appointment of Jeffery Blazevich as the new Chief Financial Officer.
BioDuro Announces New Leadership Positions for Continued Expansion
BioDuro, LLC, a leading drug discovery and development services organization, announced today the appointment of four senior leadership positions, including David Hedden, Ph.D. (Chief Scientific Officer), Brett Truitt, MS, MBA (Vice President, cGMP Operations), Mohan Thiruvazhi, Ph.D. (Vice President, Business Development), and Raymond Li, CPA, MBA (Vice President, Finance).
BioDuro partners with Advent International
Advent's strategic investment will strengthen BioDuro's leadership position as a trusted global provider of drug discovery and development services [27-January-2019] SAN DIEGO , BEIJING and SHANGHAI , Jan. 27, 2019 /PRNewswire/ -- BioDuro, a leading global life sciences contract research and development organization, and Advent International, one of the largest and m
MilliporeSigma Signs Exclusive OEM Agreement with BioDuro, LLC
AISF was developed through a research collaboration with Pfizer Inc.
BioDuro Launches New Drug Discovery Site in San Diego, CA
Suite of chemistry and biology capabilities help drug developers advance into the clinic with confidence
BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
New reagent serves as a stable, solid alternative to toxic sulfuryl fluoride gas.
BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities
Company adds 100,000 tumors to portfolio; enables broad access to proven technology platform.
BioDuro Announces Cooperation Agreement With Porton Pharma Solutions
Under this agreement, BioDuro will promote and market Porton's extensive and proven capabilities for pilot and large-scale GMP production of custom APIs and drug intermediates.
BioDuro, LLC Launches Humanized Tumor Microenvironment, Three-Dimensional Drug Screening And Patient-Derived Xenograft Verification Platform: hTME-3DX Screen And Verify
BioDuro, LLC Increases Spray Dried Drug Product Manufacturing Capacity
BioDuro, LLC Completes Infrastructure Expansion In Shanghai To Accommodate 130 Additional Chemistry And Biology Staff For Its Integrated Drug Discovery And Development Programs And To Enable Rapid Scale Up For Process-Chemistry
BioDuro, LLC Launches As Unique Contract Research And Drug Manufacturing Organization